Stockholders' Equity (Deficit) (Tables)

9 Months Ended

Sep. 30, 2022

Equity [Abstract]

Schedule of warrants

The following represents a summary of warrants for the nine months ended September 30, 2022 and the year ended December 31, 2021:

	Nine Months Ended September 30, 2022				Year Ended December 31, 2021
	Number		Weighted Average Exercise Price		Number		Weighted Average Exercise Price
Beginning balance		3,161,568	$	1.60		1,090,717	$	0.00
Granted		1,017,268		2.60		2,070,851		2.40
Exercised Cashless		-		-		-		-
Forfeited		-		-		-		-
Expired		-		-		-		-
Ending balance		4,178,836	$	1.79		3,161,568	$	1.60
Warrants exercisable		4,178,836				3,161,568
Intrinsic value of warrants	$	10,468,925			$	5,706,473
Weighted Average Remaining Contractual Life (Years)		5.26

Schedule of options

The following represents a summary of options for the nine months ended September 30, 2022 and the year ended December 31, 2021:

	Nine Months Ended September 30, 2022						Year Ended December 31, 2021
	Number			Weighted Average Exercise Price			Number			Weighted Average Exercise Price
Beginning balance		4,594,688		$	2.094			1,856,250		$	0.80
Granted		2,535,000			3.60			4,087,500			2.40
Exercised		(15,000	)		(0.80	)		(10,000	)		(0.80	)
Forfeited		(289,688	)		(0.60	)		(1,339,062	)		(0.60	)
Expired		-			-			-			-
Ending balance		6,825,000		$	0.1368			4,594,688		$	2.094
Vested options		1,610,506						1,410,938
Nonvested options		5,214,494						3,183,750
Intrinsic value of options	$	12,876,650					$	6,140,313
Weighted Average Remaining Contractual Life (Years)		6.14						6.21

Schedule of Stock Options, Valuation Assumptions

The following assumptions were used for the periods as follows:

	Nine Months Ended September 30, 2022			Year Ended December 31, 2021
Expected term		7 years			7 years
Expected volatility		114 – 126	%		135 – 177	%
Expected dividend yield		-			-
Risk-free interest rate		2.00 – 2.85	%		0.10	%